lobbying_filings_raw: eabbdcc0-290a-4ebf-a1fb-5cdfd54f9bbb
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| eabbdcc0-290a-4ebf-a1fb-5cdfd54f9bbb | Q2 | 400671007 | TAUZIN CONSULTANTS, LLC | 194014 | SCILEX HOLDING COMPANY | 2021 | second_quarter | 2021-07-12T10:50:31.850000-04:00 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/eabbdcc0-290a-4ebf-a1fb-5cdfd54f9bbb/", "filing_uuid": "eabbdcc0-290a-4ebf-a1fb-5cdfd54f9bbb", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2021, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/eabbdcc0-290a-4ebf-a1fb-5cdfd54f9bbb/print/", "filing_document_content_type": "text/html", "income": null, "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Michael D. Meirovitz", "dt_posted": "2021-07-12T10:50:31.850000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": "United States of America", "registrant_address_1": "600 St George Ave", "registrant_address_2": "Suite 6B", "registrant_different_address": false, "registrant_city": "New Orleans", "registrant_state": "LA", "registrant_zip": "70121", "registrant": {"id": 400671007, "url": "https://lda.senate.gov/api/v1/registrants/400671007/", "house_registrant_id": null, "name": "TAUZIN CONSULTANTS, LLC", "description": "â\u20ac\u2039Government relations, business development, and business incubation firm.", "address_1": "216 Landry Lane", "address_2": null, "address_3": null, "address_4": null, "city": "Thibodaux", "state": "LA", "state_display": "Louisiana", "zip": "70301", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "THOMAS TAUZIN", "contact_telephone": "+1 917-992-0108", "dt_updated": "2026-01-29T19:42:14.814431-05:00"}, "client": {"id": 194014, "url": "https://lda.senate.gov/api/v1/clients/194014/", "client_id": 381, "name": "SCILEX HOLDING COMPANY", "general_description": "Pharmaceutical company; subsidiary of Sorrento Therapeutics", "client_government_entity": false, "client_self_select": null, "state": "CA", "state_display": "California", "country": "US", "country_display": "United States of America", "ppb_state": "CA", "ppb_state_display": "California", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2019-05-01"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Issues related to fair competition, the generic drug market, drug costs, pain management, non-opioid alternatives, and prior authorization. Also issues related to COVID-19.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 52797, "prefix": null, "prefix_display": null, "first_name": "THOMAS", "nickname": null, "middle_name": null, "last_name": "TAUZIN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63790, "prefix": null, "prefix_display": null, "first_name": "MIMI", "nickname": null, "middle_name": null, "last_name": "SIMONEAUX KNEUER", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Assistant, Legislative Director, Chief of Staff, Rep. Tauzin", "new": false}, {"lobbyist": {"id": 59727, "prefix": "mr", "prefix_display": "MR.", "first_name": "MICHAEL", "nickname": null, "middle_name": "DAVID", "last_name": "MEIROVITZ", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Issues related to fair competition, the generic drug market, drug costs, pain management, non-opioid alternatives, and prior authorization. Also issues related to COVID-19.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 52797, "prefix": null, "prefix_display": null, "first_name": "THOMAS", "nickname": null, "middle_name": null, "last_name": "TAUZIN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 63790, "prefix": null, "prefix_display": null, "first_name": "MIMI", "nickname": null, "middle_name": null, "last_name": "SIMONEAUX KNEUER", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Assistant, Legislative Director, Chief of Staff, Rep. Tauzin", "new": false}, {"lobbyist": {"id": 59727, "prefix": "mr", "prefix_display": "MR.", "first_name": "MICHAEL", "nickname": null, "middle_name": "DAVID", "last_name": "MEIROVITZ", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |